Guest Columns
-
Building Frameworks To Support Complex Therapy Manufacturing
1/16/2025
To make its clinical product, CLBR001+SWI019, the Calibr-Skaggs Institute for Innovative Medicines relies on a complex network of contractors from around the globe.
-
New Regulatory Survey Findings: Biotech Global Market Access Challenges And Learnings
1/15/2025
To understand biotech companies’ evolving geographic strategies and perceptions, Arriello recently commissioned a transatlantic survey among regulatory, safety, and quality directors at small/medium biotechs, with respondents in Ireland and North America.
-
Host Cell DNA Impurities: A Unique Challenge For rAAV
1/10/2025
The potential safety impact of residual hcDNA remains largely unknown, but researchers at UCB are investigating to learn more and mitigate if necessary.
-
Tune Therapeutics' 2025 Epigenome Editing Outlook
1/10/2025
Chief Scientific Officer Derek Jantz talks about recent key innovations in gene therapy and RNA technology while considering what milestones we might see in 2025.
-
CTMC's 2025 Cell Therapy Manufacturing Outlook
1/10/2025
CEO Jason Bock looks back on milestones of 2024, namely an approved TIL for melanoma, and explains how it sets the stage for this year.
-
Hear Me Out — Cell Therapy GMP Starts With The Donor
1/9/2025
Regulators also have indicated they expect allogeneic cell therapy donors to meet more rigid eligibility requirements and undergo screening.
-
A Justification For Using In-Process Controls In Place Of Cleaning Validation
1/9/2025
This article provides a procedure for using and cleaning shared columns and column packing equipment and using in-process controls that eliminate the need for cleaning validation.
-
7 Focus Areas To Establish A Win-Win Relationship With Your CDMO
1/7/2025
Working with a CDMO doesn’t always go as planned. This article outlines the factors that will impact project success and set up a “win-win” relationship.
-
Deploy AI To Become A cGMP 'Special Agent' With A License To Care
1/7/2025
Addressing systemic cGMP issues requires more than technical fixes — it demands organizational transformation. Thoughtfully applied, AI can empower professionals to become "special agents" of quality, equipped with a "license to care."
-
11 Key Contributing Factors For Maintaining Sterility Assurance
1/6/2025
Containers and closures, depyrogenation, equipment, materials, personnel, and 7 more major factors all contribute to sterility assurance.